Adult Vaccines Manufactured by GlaxoSmithKline, LLC (75D30126D20935) CDC Notice of Award - 6… and 1 more item

The Virginia Department of Health has awarded contract PO05472728 to GlaxoSmithKline Holdings Inc. for the provision of adult vaccines manufactured by GlaxoSmithKline, LLC. This contract award, effective September 17, 2026, is executed under the Centers for Disease Control and Prevention (CDC) Notice of Award 6 NH231P922712-02-01 and carries a cumulative contract value of $208,949.77. The performance period spans July 1, 2026, through June 30, 2027, with deliveries directed to Beth Miller at the Virginia Department of Health.

The contract encompasses two distinct line items for adult vaccines, with unit prices of $162,980.82 and $45,968.95 respectively. Both line items reference the underlying CDC contract mechanism (75D30126D20935) and are structured as single-unit purchases. The award represents Virginia's procurement of immunization products through the federal CDC cooperative agreement framework, ensuring the state's access to approved adult vaccine formulations throughout the specified performance period.